DoW Lung Cancer Idea Development Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 5, 2026
- Amount
- $6,400,000
- Closes
- Sep 2, 2026 (in 30 days)
Classification and identifiers
- Solicitation number
- HT942526LCRPIDA
- Assistance listing (CFDA)
- 12.420
Amount
$6,400,000
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Idea Development Award (IDA) supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from lung cancer. This mechanism promotes new ideas that are in the early stages of development and have the potential to yield impactful data and new avenues of investigation. Research must address at least one of the FY26 LCRP areas of emphasis. Distinctive Features: This FY26 LCRP IDA mechanism has a New Investigator category that is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators. Preliminary data to support the...
Related opportunities
- DoW Prostate Cancer, Idea Development AwardDefense Health Agency Contracting Activity - DHACACloses in 30 days
- DoW Peer Reviewed Cancer, Idea AwardDefense Health Agency Contracting Activity - DHACACloses in 63 days
- DoW Pancreatic Cancer Research Program, Idea Development AwardDefense Health Agency Contracting Activity - DHACACloses in 65 days
- DoW, Peer Reviewed Cancer, Impact AwardDefense Health Agency Contracting Activity - DHACACloses in 63 days
- DoW Peer Reviewed Cancer, Clinical Trial AwardDefense Health Agency Contracting Activity - DHACACloses in 63 days
- DoW Autism Idea Development AwardDefense Health Agency Contracting Activity - DHACACloses in 80 days